Adalimumab or infliximab for the prevention or treatment of post-operative recurrence in Crohn's disease
- PMID: 23021875
- DOI: 10.1016/j.crohns.2012.09.011
Adalimumab or infliximab for the prevention or treatment of post-operative recurrence in Crohn's disease
Comment in
-
Reply to Dr. Yamamoto's letter.J Crohns Colitis. 2013 May;7(4):e158. doi: 10.1016/j.crohns.2012.09.013. Epub 2012 Oct 2. J Crohns Colitis. 2013. PMID: 23040450 No abstract available.
Comment on
-
Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.J Crohns Colitis. 2012 Oct;6(9):924-31. doi: 10.1016/j.crohns.2012.02.012. Epub 2012 Mar 15. J Crohns Colitis. 2012. PMID: 22424843 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical